Natco Pharma Ltd has received approval from the US Food and Drug Administration for its Abbreviated New Drug Application for Lansoprazole Delayed Release Capsules for the prescription market.

The drug is indicated for the treatment of gastric (stomach) ulcers. Shipments of this product will commence immediately, the Hyderabad-based company said in a release.

social-fb COMMENT NOW